NSE · ALKEM
Alkem Laboratories Limited
Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.
Market cap rank
#173
of 5,072 stocks
▼ 31W
Peak #170 · 21 Sep 2026
A largecap name in Healthcare, Alkem Laboratories Limited is well-owned by domestic institutions (23% DII), is growing revenue at a solid clip, and commands a premium earnings multiple.
Market Cap
63,050.67 Cr
P/E Ratio
27.40
P/B Ratio
4.39
ROE
16.39%
ROCE
19.93%
Dividend Yield
1.00%
52W High
—
52W Low
—
Quarterly financials
| Metric | Q1 2026-27 | Q4 2025-26 | Q3 2025-26 | Q2 2025-26 |
|---|---|---|---|---|
| Revenue | 3,740.15 Cr | 3,603.32 Cr | 3,736.82 Cr | 4,000.99 Cr |
| Net Profit | 520.98 Cr | 251.11 Cr | 653.03 Cr | 779.11 Cr |
| EPS | 43.49 | 19.77 | 53.19 | 63.99 |
| Operating Profit | 818.61 Cr | 611.70 Cr | 876.09 Cr | 930.85 Cr |
Shareholding pattern
Promoter
49.70%
Public
50.30%
PUBLIC BREAKDOWN
FII
10.42%
DII
22.63%
MF (within DII)
16.71%
Individuals
17.10%
Mutual fund holdings
₹10,866.06
Cr total
186
Schemes
31
Fund Houses
₹10,866.06 Cr
Total Exposure
HDFC Mutual Fund₹3,194.97 Cr (29.4%)
ICICI Prudential Mutual Fund₹1,695.91 Cr (15.6%)
DSP Mutual Fund₹1,622.62 Cr (14.9%)
Nippon India Mutual Fund₹1,149.47 Cr (10.6%)
SBI Mutual Fund₹926.85 Cr (8.5%)
Others₹2,276.24 Cr (20.9%)
Recent corporate actions
| Ex-Date | Type | Details |
|---|---|---|
| 07 Aug 2026 | Dividend | Dividend - Rs 10 Per Share |
| 20 Feb 2026 | Dividend | Interim Dividend - Rs 43 Per Share |
| 08 Aug 2025 | Dividend | Dividend - Rs 8 Per Share |
| 14 Feb 2025 | Dividend | Interim Dividend - Rs 37 Per Share |
| 09 Aug 2024 | Dividend | Dividend - Rs 5 Per Share |
Need this data in your app?
Full price history, technical indicators, and every field above via one REST API call.